Plasma Proteomics Identifies Thousand‐and‐One–Amino Acid Kinase 3 as a Potential Biomarker of Rheumatoid Arthritis Activity and a Novel Therapeutic Target
Arthritis & Rheumatology · 2026
DOI: 10.1002/art.70020 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arthritis & Rheumatology, 2026. Verfasst von Pengfei Xin und 15 weiteren Autor:innen. Beteiligte Einrichtung: Guanghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the National Natural Science Foundation of China, the Shanghai Science and Technology Commission Support Project, the Changning National Master of Traditional Chinese Medicine Studio.
Abstract (Originalsprache)
Objective
Bone destruction associated with active rheumatoid arthritis (RA) remains a major therapeutic challenge, with a lack of reliable molecular markers reflecting bone injury. This study aims to identify novel biomarkers linked to bone destruction in active RA through proteomic analysis, providing new strategies for precise monitoring and targeted therapy.
Methods
Data‐independent acquisition mass spectrometry was used for proteomic quantification and bioinformatic analysis on plasma samples from 160 patients with RA and 40 healthy controls. Key proteins associated with bone destruction were screened by integrating Sharp scores with synovial single‐cell RNA sequencing data and subsequently validated in two independent cohorts (N 1 = 50 and N 2 = 10) using enzyme‐linked immunosorbent assay and multiplex immunohistochemistry. Functional studies were conducted using fibroblast‐like synoviocytes (FLSs) in vitro and a collagen‐induced arthritis (CIA) mouse model in vivo.
Results
A total of 4,998 plasma proteins were identified, with 506 showing significant differential expression between active and remitted RA. Thousand‐and‐one–amino acid kinase 3 (TAOK3) levels were positively associated with Sharp scores and markedly elevated in patients with active RA. Combining TAOK3 with C‐reactive protein improved diagnostic accuracy for active RA (area under the curve = 0.915). High TAOK3 expression was also associated with increased relapse frequency. Functional studies showed that TAOK3 knockdown suppressed the tumor‐like phenotype of FLSs and down‐regulated matrix metalloproteinase 1/2/3 and cathepsin K, whereas TAOK3 overexpression promoted pannus cell–mediated bone erosion, mitigated by TAOK3‐targeted inhibitor. In vivo, its inhibition showed therapeutic effects in CIA mice.
Conclusion
TAOK3 serves as a potential biomarker for bone destruction in active RA and as a therapeutic target for precision monitoring and intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Guanghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.
- The Research Institute for Joint Diseases, Shanghai Academy of Traditional Chinese Medicine, Shanghai, China.
- Longhua Hospital Shanghai University of Traditional Chinese Medicine, Jiangxi Hospital, Nanchang, China.
- Shanghai-MOST Key Laboratory of Health and Disease Genomics, Shanghai Institute for Biomedical and Pharmaceutical Technologies, Fudan University, Shanghai, China.
- Wuxi Affiliated Hospital of Nanjing University of Chinese Medicine, Wuxi, China.
- National Key Laboratory of Immune Response and Immunotherapy, Shanghai Institute of Immunity and Infection, Chinese Academy of Sciences, Shanghai, China.
ORCID-Profile: Lu Xie, Lianbo Xiao
Förderung
- the National Natural Science Foundation of China
- the Shanghai Science and Technology Commission Support Project
- the Changning National Master of Traditional Chinese Medicine Studio
Zitieren
APA
Xin, P., Li, W., A, X., Shen, J., Meng, X., Bian, Y., Han, H., Xiang, Z., Ran, L., Sun, S., Xie, J., Yue, T., Zhu, Q., Zhang, X., Xie, L., & Xiao, L. (2026). Plasma Proteomics Identifies Thousand‐and‐One–Amino Acid Kinase 3 as a Potential Biomarker of Rheumatoid Arthritis Activity and a Novel Therapeutic Target. Arthritis & Rheumatology. https://doi.org/10.1002/art.70020
Vancouver
Xin P, Li W, A X, Shen J, Meng X, Bian Y, et al. Plasma Proteomics Identifies Thousand‐and‐One–Amino Acid Kinase 3 as a Potential Biomarker of Rheumatoid Arthritis Activity and a Novel Therapeutic Target. Arthritis & Rheumatology. 2026. doi:10.1002/art.70020
BibTeX
@article{Xin2026,
author = {Xin, Pengfei and Li, Wenzhen and A, Xinyu and Shen, Jun and Meng, Xiaohui and Bian, Yanqin and Han, Haihui and Xiang, Zheng and Ran, Lei and Sun, Songtao and Xie, Jun and Yue, Tao and Zhu, Qi and Zhang, Xiaoming and Xie, Lu and Xiao, Lianbo},
title = {Plasma Proteomics Identifies Thousand‐and‐One–Amino Acid Kinase 3 as a Potential Biomarker of Rheumatoid Arthritis Activity and a Novel Therapeutic Target},
journal = {Arthritis & Rheumatology},
year = {2026},
doi = {10.1002/art.70020}
}
EUVIMED